She is an experienced Life Sciences professional with significant exposure in the biotechnological and pharmaceutical industry for the past 6 years.

Ms. Kati has a rich academic background in Molecular Biology working in various research projects across different countries since 2012.

In 2015 she completed her Master of Science in Pharmaceutical Science with Distinction at Edinburgh Napier University, and shortly after graduating she began my career in R&D in Scotland, UK. She gained experience in leading and planning development activities and familiarized herself with validation requirements for in vitro diagnostics.

Her focus was the technical transfer of processes from development to production in Switzerland.

In 2019 she worked in Medical and Commercial operations for a startup pharmaceutical services company in Dubai, UAE, having broad set of responsibilities across all business functions including medical and regulatory affairs.

In 2020, she started my journey in Pharmacovigilance with Genpharm Services, supporting the rare disease community in the MENA region.

She is currently managing all pharmacovigilance activities in the region; she is responsible for the development and implementation of the internal Pharmacovigilance system, and    she is acting as the Pharmacovigilance Officer for all safety reporting and monitoring.

Topic of Submission

Supporting the rare disease community in the MENA region